DISCOUNT-OPTIONSSCHEIN - AMGEN Share Price

DE000HD4KBH1

Real-time BOERSE MUENCHEN 01:17:00 28/05/2024 am IST
0.45 ^EUR	-8.16%

Current month	-60.18%
1 month	-63.41%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions Of Undisclosed Antibodies	27/05	AQ
Amgen : An Underrecognized Risk Factor for Heart Disease	23/05	PU
Improving treatment responses to solid tumours with trispecific TCEs	23/05	AQ
Amgen : From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation	22/05	PU

More news

Quotes 5-day view

Date	Price	Change
27/24/27	0.45	-8.16%
24/24/24	0.49	+2.08%
23/24/23	0.48	+11.63%
22/24/22	0.43	+10.26%
21/24/21	0.39	-4.88%

Real-time BOERSE MUENCHEN

Last update May 28, 2024 at 01:17 am IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	PUT
Underlying	AMGEN INC.
Issuer	UniCredit
WKN	HD4KBH
ISIN	DE000HD4KBH1
Date issued	11/04/2024
Strike	285 $
Maturity	18/09/2024 (114 Days)
Parity	10 : 1
Emission price	1.32 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.37 €
Lowest since issue	0.38 €

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

305.8 USD

Average target price

316.3 USD

Spread / Average Target

+3.41%

Consensus